Pharmacovigilance Signal Detection Framework
Detect and validate adverse event safety signals in pharmacovigilance datasets
What You Can Do
You systematically identify potential adverse event signals from large pharmacovigilance datasets using statistical disproportionality analysis, temporal trends, and stratified subgroup evaluation. Claude validates signals against case narratives, calculates confidence metrics, and prioritizes safety concerns by severity and frequency. You generate regulatory-compliant safety reports with actionable recommendations for clinical review teams.
Features
Calculate reporting ratios (ROR, PRR, EBGM) to identify adverse events occurring more frequently than expected for a drug-event pair
Identify emerging safety signals through time-series analysis, detecting when adverse event reporting accelerates or concentrates in specific periods
Evaluate signals across patient demographics, concomitant medications, dose ranges, and indication subgroups to identify vulnerable populations
Parse and evaluate individual case safety reports (ICSRs) to assess causality, severity, outcome, and dechallenge/rechallenge patterns
Identify signals correlated with specific concomitant medications or drug combinations that may potentiate adverse events
Rank signals by severity, frequency, clinical impact, and regulatory risk to focus investigation resources on highest-priority concerns
Produce FDA MedWatch, EMA periodic safety updates, and REMS compliance documentation with signal summary tables and recommendations
Verify signal detection methodology, validate statistical calculations, and confirm compliance with ICH-E2A/E2B guidelines
Example Output
Example 1: Disproportionality Signal Report
Signal: Acute Kidney Injury (Drug A)
- ROR: 2.85 (95% CI: 1.92-4.21)
- PRR: 3.12 (Chi-square: p<0.001)
- Case Count: 47 observed vs 16 expected
- Recommendation: INVESTIGATE — signal meets statistical threshold
Example 2: Subgroup Stratification
Acute Kidney Injury Signal Stratified by Age:
- Ages 65+: ROR 4.21 (n=28) — HIGH RISK
- Ages 50-64: ROR 2.15 (n=15) — MODERATE
- Ages <50: ROR 0.89 (n=4) — NO SIGNAL
Conclusion: Elderly population requires dose adjustment or enhanced monitoring
Example 3: Temporal Trend & Recommendation
QT Prolongation Cases Over 12 Months:
Jan-Mar: 3 cases | Apr-Jun: 7 cases | Jul-Sep: 14 cases | Oct-Dec: 22 cases
Trend: 18% monthly increase (p=0.003)
Recommendation: Add ECG screening to standard safety monitoring; evaluate label update for QT risk disclosure
What's Included
- Signal Detection Workflow Templates: Step-by-step procedures for systematic adverse event signal identification, validation, and escalation
- Statistical Validation Frameworks: Pre-configured calculations for ROR, PRR, EBGM, and other disproportionality metrics with confidence interval computation
- Risk Stratification Matrices: Decision support tools for severity assessment, population vulnerability evaluation, and clinical impact scoring
- Regulatory Reporting Templates: FDA MedWatch, EMA PSUSARs, and REMS documentation formats with automated summary table generation
- Case Evaluation Checklists: Quality assurance guides for case narrative assessment, causality evaluation (Naranjo/WHO-UMC), and outcome classification
Who It's For
- Pharmacovigilance Specialists
- Drug Safety Officers
- Regulatory Affairs Professionals
- Clinical Trial Safety Monitors
- Post-Market Surveillance Teams
Best For
- Post-market safety signal monitoring
- Adverse event signal investigation and validation
- Regulatory submission and periodic safety report preparation
- Clinical trial blinded safety reviews
- Drug interaction and subgroup safety analysis
You might also like
This skill analyzes your hardware inventory data to identify aging assets, predict replacement timelines, and calculate total cost of ownership. It generates actionable lifecycle recommendations tailored to your business constraints and compliance requirements. You'll produce professional compliance reports that demonstrate audit readiness and optimize your IT asset spending.
by najicham
Analyze FDA guidance documents, structure regulatory narratives for IND/NDA/BLA submissions, and develop data-driven submission strategies aligned with current regulatory expectations. Claude identifies compliance gaps, predicts likely deficiency questions, and delivers submission-ready content formatted according to FDA conventions.
by najicham
Analyze adverse event data to identify emerging safety signals, systematically evaluate causal relationships between drugs and adverse events using established frameworks, and generate regulatory-compliant reports for submission. You'll accelerate signal detection workflows, ensure consistent application of causality assessment scales (Naranjo, WHO-UMC), and standardize your pharmacovigilance documentation for FDA, EMA, and ICH submissions.
by najicham
Navigate the complex EMA/ICH submission process by generating structured Common Technical Document (CTD) frameworks, compliance checklists, and quality assessment strategies. You'll accelerate dossier preparation, reduce submission delays, and ensure all regulatory requirements are systematically addressed before filing.
by najicham
You can quickly draft, review, and update pharmaceutical product labels that meet FDA regulations and current guidance documents. The skill ensures consistent formatting of warnings, precautions, dosage instructions, and all required disclosures—saving you hours of manual compliance checking and reducing the risk of regulatory rejection. You'll get detailed markup with specific citations to relevant FDA guidance.
by najicham
This skill guides you through systematic Linux troubleshooting using Claude to analyze system logs, performance metrics, and configuration files. You'll identify root causes of system issues, optimize resource usage, and automate remediation tasks. Claude helps you parse complex diagnostic output and recommend fixes you can apply immediately.
by najicham
Claude creates comprehensive hardware diagnostic workflows, support ticket templates, and resolution guides tailored to your infrastructure. You get structured troubleshooting trees, step-by-step repair procedures, and automated ticket routing logic—reducing MTTR while standardizing IT support across your organization.
by najicham
Systematically diagnose and resolve GCP performance, reliability, and cost issues by analyzing logs, metrics, and traces. You get structured troubleshooting workflows that pinpoint root causes—whether it's database latency, resource exhaustion, misconfigurations, or budget overruns—and deliver actionable remediation steps.
by najicham